Skip to main content
. 2022 Mar 3;41(3):342–350. doi: 10.23876/j.krcp.21.184

Table 1.

Demographic details, clinical characteristics, and laboratory parameters of the study subjects

Factor Dialysis group Control group
Demographics
 No. of patients 72 72
 Sex
  Male 58 (80.6) 24 (33.3)
  Female 14 (19.4) 48 (66.7)
 Age (yr) 46.14 ± 8.89 40.35 ± 6.65
Clinical characteristics
 Body mass index (kg/m2) 20.87 ± 4.26 23.12 ± 3.35
 Diabetes mellitus 20 (27.8) 4 (5.6)
 Hypertension 48 (66.7) 2 (2.8)
 Dilated cardiomyopathy 4 (5.6) -
 Cerebrovascular accident 4 (5.6) -
 Hypothyroidism 2 (2.8) -
 HCV infection 36 (50.0) -
Blood pressure (mmHg)
 Systolic blood pressure 145.81 ± 15.10 127.56 ± 6.20
 Diastolic blood pressure 94.77 ± 10.63 79.12 ± 4.21
Native kidney disease
 Diabetic kidney disease 18 (25.0) -
 Chronic glomerulonephritis 14 (19.4) -
 Chronic interstitial nephritis 6 (8.3) -
 Obstructive uropathy 5 (6.9) -
 Hypertensive nephrosclerosis 3 (4.2) -
 ADPKD 2 (2.8) -
 Unknown 24 (33.3) -
Dialysis access
 Arteriovenous fistula 68 (94.4) -
 Permanent catheter 4 (5.6) -
 Dialysis adequacy (Kt/V) 1.16 ± 0.17 -
 Dialysis duration (mo) 8.65 ± 6.68 -
Laboratory parameters
 Hemoglobin (g/dL) 8.07 ± 1.33 12.69 ± 1.27
 White blood cell count (cell/mm3) 6,944.44 ± 2,770.36 8,204.17 ± 1,990.99
 Neutrophils (%) 67.85 ± 10.54 58.11 ± 9.13
 Lymphocytes (%) 22.49 ± 14.16 31.49 ± 6.72
 Neutrophil-to-lymphocyte ratio 3 (2.09 ± 5.26) 1.79 (1.38 ± 2.57)
 Creatinine (mg/dL) 7.15 ± 3.29 0.88 ± 0.17
 Sodium (mEq/L) 133.50 ± 5.22 136.49 ± 4.01
 Potassium (mEq/L) 4.49 ± 1.05 4.27 ± 0.36
 Albumin (g/dL) 3.03 ± 0.70 4.05 ± 0.37
Antibody titer (U/mL)
 Reactive titer, ≥0.8 64 (88.9) 72 (100)
 Nonreactive titer, <0.8 8 (11.1) 0 (0)

Data are expressed as number only, number (%), mean ± standard deviation, or median (interquartile range).

ADPKD, autosomal dominant polycystic kidney disease; HCV, hepatitis C virus.